Abstract
Inflammation is a complex and necessary component of an organism’s response to biological, chemical or physical stimuli. In the acute phase, cells of the immune system migrate to the site of injury in a carefully orchestrated sequence of events that is mediated by cytokines and acute phase proteins. Depending upon the degree of injury, this acute phase may be sufficient to resolve the damage and initiate healing. Persistent inflammation as a result of prolonged exposure to stimulus or an inappropriate reaction to self molecules can lead to the chronic phase, in which tissue damage and fibrosis can occur. Chronic inflammation is reported to contribute to numerous diseases including allergy, arthritis, asthma, atherosclerosis, autoimmune diseases, diabetes, and cancer, and to conditions of aging. Hematology and clinical chemistry data from standard toxicology studies can provide an initial indication of the presence and sometimes location of inflammation in the absence of specific data on the immune tissues. These data may suggest more specific immune function assays are necessary to determine the existence or mechanism(s) of immunomodulation. Although changes in hematology dynamics, acute phase proteins, complement factors and cytokines are common to virtually all inflammatory conditions and can be measured by a variety of techniques, individual biomarkers have yet to be strongly associated with specific pathologic events. The specific profile in a given inflammatory condition is dependent upon species, mechanisms, severity, chronicity, and capacity of the immune system to respond and adapt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–455
NIA workshop on inflammation, inflammatory mediators, and aging. Sept. 1–2, 2004. Sponsored by National Institute on Aging, National Institutes of Health, Department of Health and Human Services. Workshop summary. Available at http://www.nia.nih.gov/NR/rdonlyres/A8B847EC-8E2B-418D-AD39-62D56E8CEAB2/2083/NIAWorkshoponInflammationMtgRpt61805_Ed.pdf. Accessed 9 Jan 2009
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
Alegre J, Jufresa J, Segura R et al (2002) Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 19:320–325
Buttarello M, Plebani M (2008) Automated blood cell counts: state of the art. Am J Clin Pathol 130:104–116
Grattan CE, Dawn G, Gibbs S, Francis DM (2003) Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 33:337–341
Zimmermann N, Hershey GK, Foster PS, Rothenberg ME (2003) Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 111:227–242
Latimer KS, Mahaffey EA, Prasse KW (eds) (2003) Duncan & Prasse’s veterinary laboratory medicine: clinical pathology, 4th edn. Iowa State Press, Ames, IA
Weyrich AS, Zimmerman GA (2004) Platelets: signaling cells in the immune continuum. Trends Immunol 25:489–495
Kosone T, Takagi H, Horiguchi N et al (2007) Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice. Lab Invest 87:284–291
González-Villalva A, Fortoul TI, Avila-Costa MR et al (2006) Thrombocytosis induced in mice after subacute and subchronic V2O5 inhalation. Toxicol Ind Health 22:113–116
Means RT, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639–1647
Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352:1012–1023
Zarychanski R, Houston DS (2008) Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ 179:333–337
Evans EW (2008) Clinical pathology as crucial insight into immunotoxicity testing. In: Bussiere JL, Herzyk D (eds) Immunotoxicology strategies for pharmaceutical safety assessment. Wiley, Hoboken, NJ, pp 13–26
Sell S (2001) Inflammation and wound healing. In: Sell S (ed) Immunology, immunopathology and immunity, 6th edn. ASM press, Washington, DC, pp 33–100
Kelly M, Hwang JM, Kubes P (2007) Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 120:3–10
Mousa SA (2002) Cell adhesion molecules: potential therapeutic and diagnostic implications. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 368–375
Sarada S, Himadri P, Mishra C, Geetail P, Ram MS, Ilavazhagan G (2008) Role of oxidative stress and NFKB in hypoxia-induced pulmonary edema. Exp Biol Med (Maywood) 233:1088–1098
Bashir MM, Sharma MR, Werth VP (2009) TNF-alpha production in the skin. Arch Dermatol Res 301:87–91
Schmid H, Boucherot A, Yasuda Y et al (2006) Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993–3003
Bachmann MF, Kopf M, Marsland BJ (2006) Chemokines: more than just road signs. Nat Rev Immunol 6:159–164
Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891–928
Abbadie C (2005) Chemokines, chemokine receptors and pain. Trends Immunol 26:529–534
Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75–84
Poznansky MC, Scadden DT, Luster AD (2002) Chemokine and chemokine receptor analysis. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 357–367
Gentry PA (1999) Acute phase proteins. In: Loeb WF, Quimby FW (eds) The clinical chemistry of laboratory animals, 2nd edn. Taylor and Francis, Philadelphia, PA, pp 336–398
Evans EW, Duncan JR (2003) Proteins, lipids and carbohydrates. In: Latimer KS, Mahaffey EA, Prasse KW (eds) Duncan & Prasse’s veterinary laboratory medicine: clinical pathology, 4th edn. Iowa State Press, Ames, IA, pp 162–192
Kushner I, Rzewnicki D, Samols D (2006) What does minor elevation of C-reactive protein signify? Am J Med 119:166e.17–166e.28
Kind CRH, Pepys MB (1984) The role of C-reactive protein (CRP) measurement in clinical practice. Int Med 5:112–151
Acevedo M, Corbalán R, Braun S, Pereira J, Navarrete C, Gonzalez I (2006) C-reactive protein and atrial fibrillation: “evidence for the presence of inflammation in the perpetuation of the arrhythmia”. Int J Cardiol 108:326–331
Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK (2002) C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144:233–238
Nesto R (2004) C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med 21:810–817
Corrado E, Rizzo M, Muratori I, Coppola G, Novo S (2006) Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 37:1004–1009
Murphy KM, Travers P, Walport M (2007) Janeway’s immunobiology, 7th edn. Garland Science Textbooks, New York
Giclas P (2002) Choosing complement tests: differentiating between hereditary and acquired deficiency. In: Rose NR, Hamilton RG, Detrick B (eds) Manual of clinical laboratory immunology, 6th edn. ASM press, Washington, DC, pp 111–116
Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM (2005) Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97:171–179
Altieri D (2001) Interface between inflammation and coagulation. In: Ley K (ed) Physiology of inflammation. Oxford University Press, Oxford, England, pp 402–422
Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184–192
Sitrin RG, Pan PM, Srikanth S, Todd RF 3rd (1998) Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol 161:1462–1470
Paraskevas KI, Baker DM, Vrentzos GE, Mikhailidis DP (2008) The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res 122:1–12
Shen Z, Want EJ, Chen W et al (2006) Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res 5:3154–3160
He QY, Yang H, Wong BC, Chiu JF (2008) Serological proteomics of gastritis: degradation of apolipoprotein A-1 and alpha-1-antitrypsin is a common response to inflammation irrespective of Helicobacter pylori infection. Dig Dis Sci 53:3112–3118
Cho WC, Yip TT, Chung WS, Leung AW, Cheng CH, Yue KK (2006) Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J Cell Biochem 99:256–268
Hanas JS, Hocker JR, Cheung JY et al (2008) Biomarker identification in human pancreatic cancer sera. Pancreas 36:61–69
Kristiansson MH, Bhat VB, Babu IR, Wishnok JS, Tannenbaum SR (2007) Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. J Proteome Res 6:1735–1744
Lull ME, Carkaci-Salli N, Freeman WM et al (2008) Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr Res 63:638–644
Wu J, Kobayashi M, Sousa EA et al (2005) Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 4:1251–1264
Ezendam J, Staedtler F, Pennings J et al (2004) Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats. Environ Health Perspect 112:782–791
Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T (2006) Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics 25:194–202
Parikh SV, de Lemos JA (2006) Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. Am J Med Sci 332:186–197
Mehra MR, Feller E, Rosenberg S (2006) The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside. Nat Clin Pract Cardiovasc Med 3:136–143
Acknowledgments
This work was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Germolec, D.R., Frawley, R.P., Evans, E. (2010). Markers of Inflammation. In: Dietert, R. (eds) Immunotoxicity Testing. Methods in Molecular Biology™, vol 598. Humana Press. https://doi.org/10.1007/978-1-60761-401-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-401-2_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-400-5
Online ISBN: 978-1-60761-401-2
eBook Packages: Springer Protocols